Publications by authors named "Atsuhiko Koeda"

Aim: Reporting of the analytical and clinical findings of synthetic cannabinoids and cathinones is essential in carrying out a complete clinical assessment of new psychoactive substances.

Methods: From 2012 to 2014, we examined synthetic cathinone and cannabinoid poisoning in six patients aged 22-42 years old. Analyses of these compounds were carried out using liquid chromatography-tandem mass spectrometry.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the risk factors for "delayed neuropsychiatric sequelae (DNS)" following acute carbon monoxide (CO) poisoning, focusing on 79 patients treated for CO poisoning in Japan.
  • Predictors of DNS included serious consciousness disturbances at admission, specific head CT findings, high levels of certain laboratory markers, and low Global Assessment Scale scores.
  • Prolonged hospital stays and more hyperbaric oxygen therapy sessions were noted in patients who developed DNS, suggesting the need for proactive treatment and follow-up care for these high-risk individuals.
View Article and Find Full Text PDF

Carbon monoxide (CO) poisoning leads to demyelination of cerebral white matter (CWM) fibers, causing chronic neuropsychiatric symptoms. To clarify whether fractional anisotropy (FA) from diffusion tensor imaging in the centrum semiovale can depict demyelination in the CWM during the subacute phase after CO inhalation, we examined correlations between FA in the centrum semiovale and myelin basic protein (MBP) in cerebrospinal fluid. Subjects comprised 26 adult CO-poisoned patients ≤60 years old.

View Article and Find Full Text PDF

Introduction: The present study aimed to detect the main regions of cerebral white matter (CWM) showing damage in the subacute phase for CO-poisoned patients with chronic neurological symptoms using voxel-based analysis (VBA) with diffusion tensor imaging (DTI).

Methods: Subjects comprised 22 adult CO-poisoned patients and 16 age-matched healthy volunteers as controls. Patients were classified into patients with transient acute symptoms only (group A) and patients with chronic neurological symptoms (group S).

View Article and Find Full Text PDF